Boston Scientific, Medinol Coronary Stent IDE Approvals Precede Legal Duel

Medinol's April 2001 lawsuit alleging Boston Scientific's development of the Express stent constitutes a breach of contract will likely be heard in New York federal court by late summer

More from Archive

More from Medtech Insight